- Home
- CAQ vs SRZN Comparison
CAQ vs SRZN Comparison
Compare CAQ & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$22.42
Company Overview
Basic Information| Metric | CAQ | SRZN |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.9M | 271.6M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CAQ | SRZN |
|---|---|---|
| Price | $9.99 | $22.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 86.1K | ★ 255.4K |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,477,000.00 |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.90 | $11.30 |
| 52 Week High | $10.01 | $35.00 |
Technical Indicators
Market Signals| Indicator | CAQ | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 48.01 |
| Support Level | $9.91 | $20.26 |
| Resistance Level | $10.01 | $24.13 |
| Average True Range (ATR) | 0.01 | 1.40 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 77.78 | 8.67 |
Price Performance
Historical Comparison CAQ
SRZN
About CAQ Cambridge Acquisition Corp. Class A Ordinary Shares
Cambridge Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).